Palo Alto Investors LLC 13D and 13G filings for Karyopharm Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:52 pm Sale |
2023-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI |
Palo Alto Investors LLC | 340,146 4.450% |
-36,899 (-9.79%) |
Filing |
| 2023-02-14 4:21 pm Purchase |
2022-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI |
Palo Alto Investors LLC | 377,045 5.000% |
12,348 (+3.39%) |
Filing |
| 2022-02-14 5:09 pm Purchase |
2021-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI |
Palo Alto Investors LLC | 364,697 7.240% |
13,520 (+3.85%) |
Filing |
| 2021-02-16 4:41 pm Purchase |
2020-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI |
Palo Alto Investors LLC | 351,177 7.160% |
44,843 (+14.64%) |
Filing |